Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Consolidated Diluted EPS At -3.9588

0

For the year ended 2015-12-31 Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) basic consolidated EPS came $-3.9588. Furthermore, for the quarter closed 2015-12-31, it was $-3.9588.

Consolidated diluted EPS

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) consolidated diluted EPS was -3.9588 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it stood at $-3.9588.

EPS contribution from parent

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) basic EPS was $-3.9588 for the year ended 2015-12-31 from its parent entity. It was $-3.9588 for the quarter closed 2015-12-31.

EPS from continuing operations

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) EPS from continuing activities was $-3.9588 for the fiscal ended 2015-12-31. For the quarter ended 2015-12-31, this figure was $-3.9588.

Basic net EPS

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) basic net EPS was $-3.96 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it came at $-3.96.

Diluted EPS from parent

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) diluted EPS from parent entity came at $-3.9588 for the year ended 2015-12-31. For the quarter ended 2015-12-31 it was $-3.9588.

Net diluted EPS

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) net diluted EPS was $-3.96 for the fiscal closed 2015-12-31. For the quarter ended 2015-12-31, net diluted EPS was $-3.96.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) net basic EPS was $-3.96 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it was $-3.96.

Basic diluted EPS

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) basic diluted EPS was $-1.3538 for the quarter ended 2015-12-31. For the year ended 2015-12-31, basic diluted EPS was $-1.3538.

For the year ended 2015-12-31, basic shares outstanding were 36.783 while for the quarter ended 2015-12-31 is 36.783.

For the fiscal ended 2015-12-31, the diluted outstanding shares were 36.783 and for the quarter ended 2015-12-31 it was 36.783. Earnings per share and diluted EPS are profitability metrics used in fundamental analysis of firms. EPS just takes into account a firm’s common shares, while diluted EPS considers all convertible securities. Per-share earnings measure the quantum of a company’s earnings on a per share basis. Basic EPS does not consider any dilutive impact that convertible securities leave on EPS. On contrary, diluted EPS is a tool used in fundamental study to gauge a firm’s quality of EPS, assuming there is conversion of all convertible securities.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 18 times, 1 visits today)